# The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance

> **NCT04831047** · PHASE4 · COMPLETED · sponsor: **University of Miami** · enrollment: 114 (actual)

## Conditions studied

- Ptosis, Eyelid
- Conjunctiva Inflamed
- Eye Manifestations

## Interventions

- **DRUG:** Oxymetazoline hydrochloride 0.1% ophthalmic solution
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04831047
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-08
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-04-01
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2023-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04831047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04831047, "The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04831047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*